AURE vs ACRV
Comparison between Aurelion Inc - Class A (AURE, Company) and Acrivon Therapeutics Inc (ACRV, Company).
AURE is from the Financial Services sector, while ACRV is from the Healthcare sector.
AURE vs ACRV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
AURE
$65M
ACRV
$65M
Max Drawdown
Winner
AURE
91.69%
ACRV
95.47%
Sharpe Ratio
AURE
-0.23
Winner
ACRV
0.62
5Y Beta
Winner
AURE
0.66
ACRV
1.80
Industry
AURE
Capital Markets
ACRV
Biotechnology
P/E Ratio
AURE
-0.39
Winner
ACRV
-0.72
Debt to Equity
AURE
35.66%
Winner
ACRV
0.00%
Free Cash Flow Yield
AURE
-0.13%
ACRV
N/A
P/S Ratio
AURE
35.87
ACRV
N/A
P/B Ratio
Winner
AURE
0.55
ACRV
0.78
AURE vs ACRV - Historical Returns
Returns include dividend reinvestment.
1M
AURE
-23.42%
Winner
ACRV
-1.23%
3M
AURE
-32.00%
Winner
ACRV
-16.23%
6M
AURE
-41.78%
Winner
ACRV
-21.95%
1Y
AURE
-61.36%
Winner
ACRV
+15.11%
Max(CAGR)
AURE
-57.70%
Winner
ACRV
-47.01%
AURE vs ACRV - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | AURE | ACRV |
|---|---|---|
| 2026 | -39.29% | -34.96% |
| 2025 | -81.90% | -57.64% |
| 2024 | -9.09% | +20.16% |
| 2023 | N/A | -57.48% |
| 2022 | N/A | -30.77% |
AURE vs ACRV Drawdown Comparison
The maximum drawdown for AURE was -91.69%, occurring on Jul 10, 2026. This drawdown has not yet recovered.
The maximum drawdown for ACRV was -95.47%, occurring on May 30, 2025. This drawdown has not yet recovered.
The current AURE drawdown is -90.45%. The current ACRV drawdown is -93.10%.
| Rank | AURE | ACRV |
|---|---|---|
| #1 | -91.69% Dec 9, 2024 - Jul 10, 2026 | -95.47% Feb 14, 2023 - May 30, 2025 |
| #2 | -62.05% Feb 14, 2024 - Dec 9, 2024 | -32.24% Nov 16, 2022 - Feb 2, 2023 |
| #3 | -19.31% Feb 2, 2024 - Feb 12, 2024 | -2.62% Feb 8, 2023 - Feb 13, 2023 |
Correlation
Correlation between AURE and ACRV is 0.78 which considered as a strong positive correlation - the stocks tend to move together.
0.78
-101
Select Stocks to Compare
Popular: AURE vs SPYACRV vs SPY
More Comparisons
Compare with similar stocks